Trial intelligence / Profile preview

PVP-I Nasal Sprays vs Saline in COVID-19

NCT04347954Phase 2Completed

Sponsor
Stanford University
Start
Aug 2020
Primary completion
Dec 2020
Modality
Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of IVIEW-1502 in coronavirus disease 2019 (COVID-19), sponsored by Stanford University. Started Aug 2020; status: completed.

02

Drugs

IVIEW-1502
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04347954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04347954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call